These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 1421186

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [In vivo 31P-cardiac magnetic resonance spectroscopy: methods and the first clinical results].
    Krahe T, Schindler R, Neubauer S, Hillenbrand H, Lackner K, Boesiger P, McKinnon G, Landwehr P, Ertl G.
    Rofo; 1991 Dec; 155(6):506-12. PubMed ID: 1764590
    [Abstract] [Full Text] [Related]

  • 7. Impaired left ventricular energy metabolism in patients with hypertrophic cardiomyopathy is related to the extension of fibrosis at delayed gadolinium-enhanced magnetic resonance imaging.
    Esposito A, De Cobelli F, Perseghin G, Pieroni M, Belloni E, Mellone R, Canu T, Gentinetta F, Scifo P, Chimenti C, Frustaci A, Luzi L, Maseri A, Maschio AD.
    Heart; 2009 Mar; 95(3):228-33. PubMed ID: 18708417
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The relationship between plasma BNP level and the myocardial phosphocreatine/adenosine triphosphate ratio determined by phosphorus-31 magnetic resonance spectroscopy in patients with dilated cardiomyopathy.
    Chida K, Otani H, Kohzuki M, Saito H, Kagaya Y, Takai Y, Takahashi S, Yamada S, Zuguchi M.
    Cardiology; 2006 Mar; 106(3):132-6. PubMed ID: 16636542
    [Abstract] [Full Text] [Related]

  • 10. Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy.
    Neubauer S, Horn M, Cramer M, Harre K, Newell JB, Peters W, Pabst T, Ertl G, Hahn D, Ingwall JS, Kochsiek K.
    Circulation; 1997 Oct 07; 96(7):2190-6. PubMed ID: 9337189
    [Abstract] [Full Text] [Related]

  • 11. Cardiac metabolism and function in patients with multiple sclerosis: a combined 31P-MR-spectroscopy and MRI study.
    Beer M, Sandstede J, Weilbach F, Spindler M, Buchner S, Krug A, Köstler H, Pabst T, Kenn W, Landschütz W, von Kienlin M, Toyka KV, Ertl G, Gold R, Hahn D.
    Rofo; 2001 May 07; 173(5):399-404. PubMed ID: 11414146
    [Abstract] [Full Text] [Related]

  • 12. Phosphorus-31 nuclear magnetic resonance analysis of transient changes of canine myocardial metabolism in vivo.
    Heineman FW, Balaban RS.
    J Clin Invest; 1990 Mar 07; 85(3):843-52. PubMed ID: 2312728
    [Abstract] [Full Text] [Related]

  • 13. (31)P magnetic resonance spectroscopy to measure in vivo cardiac energetics in normal myocardium and hypertrophic cardiomyopathy: Experiences at 3T.
    Shivu GN, Abozguia K, Phan TT, Ahmed I, Henning A, Frenneaux M.
    Eur J Radiol; 2010 Feb 07; 73(2):255-9. PubMed ID: 19056193
    [Abstract] [Full Text] [Related]

  • 14. [31P-NMR analysis of high energy phosphorous compounds (ATP and phosphocreatine) in the living rat brain--effects of halothane anesthesia and a hypoxic condition].
    Yuasa T, Miyatake T, Kuwabara T, Umeda M, Eguchi K.
    No To Shinkei; 1983 Nov 07; 35(11):1089-95. PubMed ID: 6661335
    [Abstract] [Full Text] [Related]

  • 15. Open-chest 31P magnetic resonance spectroscopy of mouse heart at 4.7 Tesla.
    Lee J, Hu Q, Nakamura Y, Wang X, Zhang X, Zhu X, Chen W, Yang Q, Zhang J.
    J Magn Reson Imaging; 2006 Dec 07; 24(6):1269-76. PubMed ID: 17096395
    [Abstract] [Full Text] [Related]

  • 16. Phosphorus nuclear magnetic resonance: a non-invasive technique for the study of muscle bioenergetics during exercise.
    Sapega AA, Sokolow DP, Graham TJ, Chance B.
    Med Sci Sports Exerc; 1987 Aug 07; 19(4):410-20. PubMed ID: 3309542
    [Abstract] [Full Text] [Related]

  • 17. Altered myocardial high-energy phosphate metabolites in patients with dilated cardiomyopathy.
    Hardy CJ, Weiss RG, Bottomley PA, Gerstenblith G.
    Am Heart J; 1991 Sep 07; 122(3 Pt 1):795-801. PubMed ID: 1877457
    [Abstract] [Full Text] [Related]

  • 18. Normal and diffusely abnormal myocardium in humans: functional and metabolic characterization with P-31 MR spectroscopy and cine MR imaging.
    Auffermann W, Chew WM, Wolfe CL, Tavares NJ, Parmley WW, Semelka RC, Donnelly T, Chatterjee K, Higgins CB.
    Radiology; 1991 Apr 07; 179(1):253-9. PubMed ID: 2006287
    [Abstract] [Full Text] [Related]

  • 19. [Evaluation of myocardial energy metabolism by 31 P-magnetic resonance spectroscopy in patients with hypertrophic cardiomyopathy versus healthy individuals].
    Mazaev VV, Stukalova OV, Ternovoĭ SK, Chazova IE.
    Vestn Rentgenol Radiol; 2012 Apr 07; (6):8-12. PubMed ID: 23520935
    [Abstract] [Full Text] [Related]

  • 20. High-energy phosphate metabolism of the myocardium in normal subjects and patients with various cardiomyopathies--the study using ECG gated MR spectroscopy with a localization technique.
    Masuda Y, Tateno Y, Ikehira H, Hashimoto T, Shishido F, Sekiya M, Imazeki Y, Imai H, Watanabe S, Inagaki Y.
    Jpn Circ J; 1992 Jun 07; 56(6):620-6. PubMed ID: 1625368
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.